Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16333838rdf:typepubmed:Citationlld:pubmed
pubmed-article:16333838lifeskim:mentionsumls-concept:C0318157lld:lifeskim
pubmed-article:16333838lifeskim:mentionsumls-concept:C0220621lld:lifeskim
pubmed-article:16333838lifeskim:mentionsumls-concept:C0243026lld:lifeskim
pubmed-article:16333838lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:16333838lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:16333838lifeskim:mentionsumls-concept:C0021149lld:lifeskim
pubmed-article:16333838lifeskim:mentionsumls-concept:C0035363lld:lifeskim
pubmed-article:16333838pubmed:issue6lld:pubmed
pubmed-article:16333838pubmed:dateCreated2006-9-14lld:pubmed
pubmed-article:16333838pubmed:abstractTextInfections remain an important cause of morbidity and mortality in children with acute myeloid leukemia (AML), and particularly viridans group streptococci (VGS) sepsis. The present study, conducted between 1993 and 2003 in children with AML, sought to assess the frequency and characteristics of infectious complications (ICs), the incidence of VGS sepsis, the interest of preventive decontamination, and a possible cytarabine dose-effect on the occurrence of ICs.lld:pubmed
pubmed-article:16333838pubmed:languageenglld:pubmed
pubmed-article:16333838pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16333838pubmed:citationSubsetIMlld:pubmed
pubmed-article:16333838pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16333838pubmed:statusMEDLINElld:pubmed
pubmed-article:16333838pubmed:monthNovlld:pubmed
pubmed-article:16333838pubmed:issn1545-5009lld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:PagesM PMPlld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:BertrandYYlld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:BarbéGGlld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:PlotonCClld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:BleyzacNNlld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:FreydièreA...lld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:GalambrunCClld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:PondarréCClld:pubmed
pubmed-article:16333838pubmed:authorpubmed-author:BrunetA SASlld:pubmed
pubmed-article:16333838pubmed:copyrightInfo(c) 2005 Wiley-Liss, Inc.lld:pubmed
pubmed-article:16333838pubmed:issnTypePrintlld:pubmed
pubmed-article:16333838pubmed:volume47lld:pubmed
pubmed-article:16333838pubmed:ownerNLMlld:pubmed
pubmed-article:16333838pubmed:authorsCompleteYlld:pubmed
pubmed-article:16333838pubmed:pagination765-72lld:pubmed
pubmed-article:16333838pubmed:dateRevised2009-1-12lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:meshHeadingpubmed-meshheading:16333838...lld:pubmed
pubmed-article:16333838pubmed:year2006lld:pubmed
pubmed-article:16333838pubmed:articleTitleLow incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.lld:pubmed
pubmed-article:16333838pubmed:affiliationClinical Hematology and Bone Marrow Transplantation Department, Debrousse Hospital, Hospices Civils de Lyon, Lyon, France.lld:pubmed
pubmed-article:16333838pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16333838lld:pubmed